secwatch.observer — SEC 8-K summary
======================================

Issuer:     Insight Molecular Diagnostics Inc. (IMDX)
CIK:        0001642380
Form:       8-K
Filed at:   2023-10-05T23:59:59+00:00
Accession:  0001493152-23-036351
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncocyte dismisses Withum, engages Marcum as independent auditor for FY 2023
----------------------------------------------------------------------------

- Withum dismissed as independent registered public accounting firm on September 29, 2023.
- Audit Committee approved Marcum LLP as new auditor for fiscal year ending December 31, 2023.
- Withum's reports for FY 2021 and FY 2022 were unqualified; no disagreements reported.
- A material weakness in internal controls was identified and remediated prior to June 30, 2023.
- Withum furnished a letter agreeing with the company's disclosures, attached as Exhibit 16.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642380/000149315223036351/0001493152-23-036351-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642380/000149315223036351/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-036351

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer